PA
WST icon

PFG Advisors’s West Pharmaceutical WST Stock Holding History

PFG Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Hold
2,989
– – 0.05% 364
2026
Q1 		$749K Sell
2,989
-65
-2% -$16.2K 0.04% 448
2025
Q4 		$840K Sell
3,054
-248
-8% -$67.8K 0.04% 413
2025
Q3 		$866K Buy
3,302
+50
+2% +$12.2K 0.04% 426
2025
Q2 		$712K Sell
3,252
-9
-0.3% -$1.92K 0.03% 354
2025
Q1 		$730K Buy
3,261
+1
+0% +$276 0.04% 389
2024
Q4 		$1.07M Sell
3,260
-351
-10% -$110K 0.07% 291
2024
Q3 		$1.08M Buy
3,611
+6
+0.2% +$1.84K 0.07% 287
2024
Q2 		$1.19M Sell
3,605
-20
-0.6% -$7.07K 0.08% 262
2024
Q1 		$1.43M Sell
3,625
-3
-0.1% -$1.11K 0.1% 221
2023
Q4 		$1.28M Sell
3,628
-4
-0.1% -$1.42K 0.1% 223
2023
Q3 		$1.36M Sell
3,632
-1
-0% -$387 0.12% 197
2023
Q2 		$1.39M Buy
3,633
+6
+0.2% +$2.14K 0.11% 226
2023
Q1 		$1.26M Buy
3,627
+1
+0% +$292 0.11% 232
2022
Q4 		$853K Hold
3,626
– – 0.08% 275
2022
Q3 		$892K Hold
3,626
– – 0.1% 242
2022
Q2 		$1.1M Buy
3,626
+29
+0.8% +$9.44K 0.12% 161
2022
Q1 		$1.48M Hold
3,597
– – 0.15% 147
2021
Q4 		$1.69M Buy
3,597
+2,579
+253% +$1.11M 0.17% 177
2021
Q3 		$432K Buy
1,018
+400
+65% +$169K 0.05% 355
2021
Q2 		$222K Buy
+618
New +$204K 0.03% 448
2021
Q1 		– Sell
-771
Closed -$218K – 473
2020
Q4 		$218K Buy
771
+81
+12% +$22.7K 0.04% 347
2020
Q3 		$202K Buy
+690
New +$183K 0.04% 341

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

PFG Advisors's WST Position: Q2 2026 in Review

PFG Advisors held its West Pharmaceutical (WST) position steady in Q2 2026 at 2,989 shares worth $1.07M. The position accounts for 0.05% of the portfolio, ranked #364.

PFG Advisors first reported a position in WST in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.69M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • PFG Advisors held 2,989 shares of West Pharmaceutical worth $1.07M as of Q2 2026.
  • PFG Advisors left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.05% of PFG Advisors's portfolio in Q2 2026, its #364 holding.
  • PFG Advisors first reported a position in West Pharmaceutical in Q3 2020 and has held it in 23 quarters since.
  • PFG Advisors's West Pharmaceutical position peaked at $1.69M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.